HIV heterosexual transmission: a hypothesis about an additional potential determinant.
暂无分享,去创建一个
D B Louria | J. Skurnick | T. Denny | C. A. Kennedy | P. Palumbo | D. Louria | C. Rohowsky-Kochan | J H Skurnick | P Palumbo | J D Bogden | C Rohowsky-Kochan | T N Denny | C A Kennedy | J. Bogden
[1] I. M. Belyakov,et al. The importance of local mucosal HIV-specific CD8(+) cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12. , 1998, The Journal of clinical investigation.
[2] I. de Vincenzi,et al. Probability of heterosexual transmission of HIV: relationship to the number of unprotected sexual contacts. European Study Group in Heterosexual Transmission of HIV. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[3] E. Fenyö,et al. Correlation between seroreactivity to HIV-1 V3 loop peptides and male-to-female heterosexual transmission. , 1993, AIDS.
[4] M. Cloyd,et al. Polymorphic human gene(s) determines differential susceptibility of CD4 lymphocytes to infection by certain HIV-1 isolates. , 1991, Virology.
[5] A. Saah,et al. Effects of micronutrient intake on survival in human immunodeficiency virus type 1 infection. , 1996, American journal of epidemiology.
[6] J. Skurnick,et al. CD3+CD8+ cell levels as predictors of transmission in human immunodeficiency virus-infected couples: a report from the heterosexual HIV transmission study. , 1998, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[7] S. Arya,et al. Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells , 1995, Science.
[8] M. Baum,et al. Micronutrient status in relationship to mortality in HIV-1 disease. , 2009, Nutrition reviews.
[9] T. Delea,et al. The Causal Role for Genital Ulcer Disease as a Risk Factor for Transmission of Human Immunodeficiency Virus: An Application of the Bradford Hill Criteria , 1996, Sexually transmitted diseases.
[10] J. Wiley,et al. Heterogeneity in the probability of HIV transmission per sexual contact: the case of male-to-female transmission in penile-vaginal intercourse. , 1989, Statistics in medicine.
[11] W. Fawzi,et al. A randomized trial of vitamin A supplements in relation to mortality among human immunodeficiency virus-infected and uninfected children in Tanzania. , 1999, The Pediatric infectious disease journal.
[12] S. Rowland-Jones,et al. Immune responses in HIV-exposed seronegatives: have they repelled the virus? , 1995, Current opinion in immunology.
[13] R. Watson,et al. Vitamins and immunomodulation in AIDS. , 1996, Nutrition.
[14] D. Richman,et al. A cross-sectional comparison of persons with syncytium- and non-syncytium-inducing human immunodeficiency virus. , 1993, The Journal of infectious diseases.
[15] P. Piot,et al. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. , 1991, The Journal of infectious diseases.
[16] R. Chandra,et al. Low serum vitamin B-12 concentrations are associated with faster human immunodeficiency virus type 1 (HIV-1) disease progression. , 1997, The Journal of nutrition.
[17] C. Khamboonruang,et al. Risk factors for HIV‐1 transmission from HIV‐seropositive male blood donors to their regular female partners in northern Thailand , 1997, AIDS.
[18] S. Holmberg,et al. Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. , 1988, JAMA.
[19] M. Robb,et al. Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group. , 1999, The Journal of infectious diseases.
[20] A. Baleta. Concern voiced over “dry sex” practices in South Africa , 1998, The Lancet.
[21] K. Tomecki. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial: Grosskurth J, Mosha F, Todd J, et al. Lancet 1995;346:530–536 , 1996 .
[22] A. Lazzarin,et al. Man-to-woman sexual transmission of HIV: longitudinal study of 343 steady partners of infected men. , 1993, Journal of acquired immune deficiency syndromes.
[23] Aileen B. Sedman,et al. A longitudinal study , 1987 .
[24] S. O’Brien,et al. C-C chemokines, pivotal in protection against HIV type 1 infection. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[25] W. Willett,et al. Dietary micronutrient intake and risk of progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1 (HIV-1)-infected homosexual men. , 1993, American journal of epidemiology.
[26] E. Fenyö,et al. Biological correlates of HIV‐1 heterosexual transmission , 1997, AIDS.
[27] Ronald H Gray,et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial , 1999, The Lancet.
[28] J. Buring,et al. Micronutrients and HIV‐1 disease progression , 1995, AIDS.
[29] L. Kingsley,et al. No association between herpes simplex virus type-2 seropositivity or anogenital lesions and HIV seroconversion among homosexual men. , 1990, Journal of acquired immune deficiency syndromes.
[30] A. Muñoz,et al. HIV infection among Female Partners of Seropositive Men in Brazil , 1995 .
[31] J. Skurnick,et al. HLA antigens associated with susceptibility/resistance to HIV-1 infection. , 1998, Human immunology.
[32] C Khamboonruang,et al. Changes in sexual behavior and a decline in HIV infection among young men in Thailand. , 1996, The New England journal of medicine.
[33] G. Satten,et al. Probability of female-to-male transmission of HIV-1 in Thailand , 1994, The Lancet.
[34] A. De Rossi,et al. HIV‐1 variability and progression to AIDS: A longitudinal study , 1990, Journal of medical virology.
[35] E. Rosenberg,et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. , 1997, Science.
[36] J. Berzofsky,et al. ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. , 1995, The Journal of clinical investigation.
[37] J. Albert,et al. Transmission of human immunodeficiency virus type 1 (HIV-1) from mother to child correlates with viral phenotype. , 1993, Virology.
[38] C. Giaquinto,et al. DNA HLA-DRB1 analysis in children of positive mothers and estimated risk of vertical HIV transmission. , 1993, Disease markers.
[39] Jw. World Health Report 1995 , 1995 .
[40] J. Skurnick,et al. Status of selected nutrients and progression of human immunodeficiency virus type 1 infection. , 2000, The American journal of clinical nutrition.
[41] S. Rowland-Jones,et al. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women , 1995, Nature Medicine.
[42] A. Saah,et al. Association between serum vitamin A and E levels and HIV‐1 disease progression , 1997, AIDS.
[43] I. Keet,et al. Prognostic Value of HIV-1 Syncytium-Inducing Phenotype for Rate of CD4+ Cell Depletion and Progression to AIDS , 1993, Annals of Internal Medicine.
[44] J. Wasserheit,et al. Epidemiological Synergy: Interrelationships between Human Immunodeficiency Virus Infection and Other Sexually Transmitted Diseases , 1992, Sexually transmitted diseases.
[45] J. Lifson,et al. Non-cytolytic CD8 T-cell anti-HIV responses in primary HIV-1 infection , 1994, The Lancet.
[46] L. Kingsley,et al. Heterosexual HIV-1 transmission and viral load in hemophilic patients. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[47] R. Scorza,et al. HLA‐associated susceptibility to HIV‐1 infection , 1992, Clinical and experimental immunology.
[48] R J Hayes,et al. The cofactor effect of genital ulcers on the per-exposure risk of HIV transmission in sub-Saharan Africa. , 1995, The Journal of tropical medicine and hygiene.
[49] M. Clerici,et al. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals , 1997, Nature Medicine.
[50] M. Barreto,et al. Effect of vitamin A supplementation on diarrhoea and acute lower-respiratory-tract infections in young children in Brazil , 1994, The Lancet.
[51] J. Bogden,et al. Micronutrient Status and Human Immunodeficiency Virus (HIV) Infection , 1990, Annals of the New York Academy of Sciences.
[52] C. Cassel,et al. Poverty and Ill Health: Physicians Can, and Should, Make a Difference , 1998, Annals of Internal Medicine.
[53] P. Kunasol,et al. Searching: Business Source Complete Choose Databases » , 2022 .
[54] J. Skurnick,et al. Micronutrient profiles in HIV-1-infected heterosexual adults. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[55] J J Goedert,et al. Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene , 1996, Science.
[56] J. Goedert,et al. HLA antigen frequencies in HIV-1 seropositive disease-free individuals and patients with AIDS. , 1988, Journal of acquired immune deficiency syndromes.
[57] J. Ward,et al. Heterosexual transmission of human immunodeficiency virus type 1 from transfusion recipients to their sex partners. , 1994, Journal of acquired immune deficiency syndromes.
[58] K. V. Bailey,et al. Use of body mass index of adults in assessing individual and community nutritional status. , 1995, Bulletin of the World Health Organization.
[59] Increased virulence of coxsackievirus B3 in mice due to vitamin E or selenium deficiency. , 1997, The Journal of nutrition.
[60] F. Valentine,et al. Lymphocytes from some long-term seronegative heterosexual partners of HIV-infected individuals proliferate in response to HIV antigens. , 1992, AIDS research and human retroviruses.
[61] J. Canner,et al. Maternal vitamin A deficiency and mother-to-child transmission of HIV-1 , 1994, The Lancet.
[62] M Subramanian,et al. The World Health Report 1995: bridging the gaps. , 1995 .
[63] Donna Spiegelman,et al. Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania , 1998, The Lancet.
[64] J. Margolick,et al. Increased mortality associated with vitamin A deficiency during human immunodeficiency virus type 1 infection. , 1993, Archives of internal medicine.
[65] L. Clemow,et al. Human immunodeficiency virus infection in sexually active wives of infected hemophilic men. , 1988, The American journal of medicine.
[66] M. Roederer,et al. Glutathione deficiency is associated with impaired survival in HIV disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[67] J. Skurnick,et al. Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[68] J. Berzofsky,et al. Human immunodeficiency virus type 1 (HIV-1)-seronegative injection drug users at risk for HIV exposure have antibodies to HLA class I antigens and T cells specific for HIV envelope. , 1996, The Journal of infectious diseases.
[69] C. Kleeberger,et al. CCR5 promoter polymorphism and HIV-1 disease progression , 1998, The Lancet.
[70] J. Albert,et al. Biological phenotypes of HIV-1 in pathogenesis and transmission. , 1994, Antibiotics and Chemotherapy.
[71] W. Ray,et al. No association between calcium channel blocker use and confirmed bleeding peptic ulcer disease. , 1998, American journal of epidemiology.
[72] J. Goedert,et al. High risk of HIV-1 infection for first-born twins , 1991, The Lancet.
[73] D B Louria,et al. Herpes simplex type II and Mycoplasma genitalium as risk factors for heterosexual HIV transmission: report from the heterosexual HIV transmission study. , 1998, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[74] R. Crystal,et al. SYSTEMIC GLUTATHIONE DEFICIENCY IN SYMPTOM-FREE HIV-SEROPOSITIVE INDIVIDUALS , 1989, The Lancet.
[75] M. Beck,et al. Rapid genomic evolution of a non-virulent Coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates , 1995, Nature Medicine.
[76] I. de Vincenzi,et al. A Longitudinal Study of Human Immunodeficiency Virus Transmission by Heterosexual Partners , 1994 .
[77] J. Cruse,et al. HLA disease association and protection in HIV infection among African Americans and Caucasians. , 1991, Pathobiology : journal of immunopathology, molecular and cellular biology.
[78] E. Vittinghoff,et al. Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: results from a ten-year study. , 1997, American journal of epidemiology.
[79] D. Stram,et al. Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients. Transfusion Safety Study Group. , 1997, American journal of epidemiology.
[80] H. Morse,et al. H-2-associated and background genes influence the development of a murine retrovirus-induced immunodeficiency syndrome. , 1990, Journal of immunology.
[81] H. Lai,et al. High risk of HIV-related mortality is associated with selenium deficiency. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[82] M. King,et al. Genetic risk factors for perinatally acquired HIV-1 infection. , 1992, Paediatric and perinatal epidemiology.
[83] L. Isa,et al. Blood zinc status and zinc treatment in human immunodeficiency virus-infected patients , 1992, International journal of clinical & laboratory research.
[84] John P. Moore,et al. HIV–1 neutralizing antibodies: How full is the bottle? , 1999, Nature Medicine.
[85] R. Osathanondh,et al. HIV-1 Langerhans' Cell Tropism Associated with Heterosexual Transmission of HIV , 1996, Science.
[86] A. Gringeri,et al. Susceptibility to HIV infection and AIDS in Italian haemophiliacs is HLA associated , 1990, British journal of haematology.
[87] P. Simmonds,et al. HLA HAPLOTYPE A1 B8 DR3 AS A RISK FACTOR FOR HIV-RELATED DISEASE , 1988, The Lancet.
[88] J. Todd,et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial , 1995, The Lancet.